Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
6
×
life sciences
national blog main
6
×
boston blog main
boston top stories
biotech
deals
editas medicine
gene editing
national top stories
san francisco blog main
boston
cancer
clinical trials
national
san francisco top stories
allergan
car-t
crispr therapeutics
cynthia collins
drugs
gene therapy
novartis
pfizer
vc
abbvie
acquisitions
administration
advanced therapies
alzheimer's
alzheimer's disease
amgen
atmp
avexis
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
biontech
bioprocess insider
bms
What
gene
6
×
crispr
editing
therapy
bio
editas
experimental
genetic
human
medicine
medicines
abbvie
access
advanced
allergan
alliance
becker
billions
biotech
blessing
bosley
cancer
capacity
car
cas
cell
cells
ceo
check
clinical
consolidation
create
cusp
defect
depart
diagnostic
diseases
dollars
drive
eaton
Language
unset
Current search:
" national blog main "
×
gene
×
crispr
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells